Dual Antithrombotic Therapy Targeting Residual Risk for Atherosclerotic Cardiovascular Disease Does Body Mass Index Matter?

被引：1
|
作者：
Martin, Karlyn [1 ]
Khan, Sadiya S. [2 ,3 ]
机构：
[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 05期
关键词：
anticoagulant; cardiovascular risk; DOAC; obesity; prevention; rivaroxaban; RIVAROXABAN; ASPIRIN; OBESE;
D O I：
10.1016/j.jacc.2020.12.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：526 / 528
页数：3
相关论文
共 50 条
  • [31] The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
    Hsuan, Chin-Feng
    Lin, Fang-Ju
    Lee, Thung-Lip
    Yang, Kai-Chien
    Tseng, Wei-Kung
    Wu, Yen-Wen
    Yin, Wei-Hsian
    Yeh, Hung-, I
    Chen, Jaw-Wen
    Wu, Chau-Chung
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
    Chin-Feng Hsuan
    Fang-Ju Lin
    Thung-Lip Lee
    Kai-Chien Yang
    Wei-Kung Tseng
    Yen-Wen Wu
    Wei-Hsian Yin
    Hung-I. Yeh
    Jaw-Wen Chen
    Chau-Chung Wu
    Scientific Reports, 12
  • [33] Index of body mass and factors of cardiovascular risk: detection for a threshold index of optimal body mass
    Smida, H
    Bouguerra, R
    Ben Salem, L
    El Ati, J
    Rayana, CH
    Blouza, S
    Achour, A
    Ben Slama, C
    Zouari, B
    DIABETES & METABOLISM, 2006, 32 : S88 - S88
  • [34] Antithrombotic Therapies and Body Mass Index Does One Size Fit All?
    Cigarroa, Joaquin E.
    Anderson, H. V. Skip
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (19) : 1961 - 1964
  • [35] Residual Atherosclerotic Cardiovascular Disease Risk in Subjects With Diabetes and Cardiovascular Disease on Statins: The ACCORD Study
    Wong, Nathan D.
    Zhao, Yanglu
    Bertoni, Alain
    Hlavacek, Patrick
    Tarasenko, Lisa
    Masseria, Cristina
    CIRCULATION, 2017, 136
  • [36] Observation cardiovascular risk associated with the body mass index
    Basdevant, A
    Verpilleux, MP
    Fiquet, B
    Yau, C
    Francillon, A
    Pannier, B
    DIABETES & METABOLISM, 2006, 32 : S87 - S87
  • [37] Body mass index and sedentarism as cardiovascular risk factors
    Garces-Ortega, Juan Pablo
    Alvarez-Ochoa, Robert
    Pacuruco Cajas, Julio Ignacio
    Quijije Castro, Jember Javier
    Toledo River, Adrian Vladimir
    Vanegas Santander, Kelly Vanessa
    Buenano Rodriguez, Christian Eduardo
    Lojano Altamirano, Daniela Alejandra
    Bueno Quizhpi, Paola Fernanda
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2023, 18 (03): : 54 - 62
  • [38] Gastrointestinal disorders and symptoms: does body mass index matter?
    van Oijen, MGH
    Josemanders, DFGM
    Laheij, RJF
    van Rossum, LGM
    Tan, ACITL
    Jansen, JBMJ
    NETHERLANDS JOURNAL OF MEDICINE, 2006, 64 (02): : 45 - 49
  • [39] Does predelivery body mass index really matter in pregnancy?
    Misan, Natalia
    Korszun, Przemyslaw
    Gruca-Stryjak, Karolina
    Paczkowska, Katarzyna
    Nowak, Aleksy
    Wozniak, Patrycja
    Ropacka-Lesiak, Mariola
    GINEKOLOGIA POLSKA, 2022, 93 (11) : 922 - 929
  • [40] Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
    Wong, Nathan D.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
12345